Intellia Therapeutics Inc (NTLA)

NASDAQ · Biotechnology

12.58
-0.49 (-3.75%)
Updated Oct 13, 4:58 AM ET
AI Rating
Hold
Overall Score
53
Trend
27
Momentum
84
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Sep 29, 2025 260 sessions Oct 9, 2026

AI Analysis

Intellia Therapeutics Inc is trading at $12.58, down 3.75% on the session. The 50 day average sits at $12.18 and the 200 day at $12.94, which puts the stock in a downtrend. RSI is at 58.1, which reads as strong, and MACD is bullish crossover. Volume is above average.

The nearest support is around $12.28 with resistance near $13.35, so that band frames the current range. Average daily movement is roughly $0.78, or about 6.2% of the share price, which is what any stop placement has to allow for. The overall health score of 53 out of 100 combines a trend score of 27, momentum of 84 and a risk score of 52.

Technical indicators

RSI (14)
58.1
strong
MACD
0.064
bullish crossover
SMA 20
12.13
SMA 50
12.18
SMA 200
12.94
downtrend
ATR (14)
0.78
avg daily range
Support
12.28
Resistance
13.35
Volume vs 20d
1.49x
above average
Volatility
58.1%
annualised
1 month
+9.56%
3 months
+0.38%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.